Clinical Trial Results:
Clinical phase II trial to evaluate the safety and efficacy of treosulfan based conditioning prior to allogenic haematopoietic stem cell transplantation in patients with haematological malignancies.
Summary
|
|
EudraCT number |
2005-005182-11 |
Trial protocol |
IT |
Global completion date |
11 Jan 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
06 Mar 2020
|
First version publication date |
01 Jan 2020
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
Summary of results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.